Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Plos One|March 11, 2024
Qualitative classification of thrombus images as a way to improve quantitative analysis of thrombus formation in flow chamber assaysPiotr Kamola, Tomasz Przygodzki
Biochimica Et Biophysica Acta|June 14, 2005
Calcium ionophore A23187 action on cardiac myocytes is accompanied by enhanced production of reactive oxygen speciesTomasz Przygodzki, Adam Sokal, Maria Bryszewska
Platelets|May 29, 2023
F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?Piotr Kamola, Anna Babinska, Tomasz Przygodzki
European Journal of Pharmacology|January 2, 2013
COX-2-derived prostaglandins do not contribute to coronary flow regulation in diabetic rats: distinct secretion patterns of PGI2 and PGE2Tomasz Przygodzki, Marcin Talar, Cezary Watala
International Journal of Molecular Sciences|November 11, 2020
Intravital Assessment of Blood Platelet Function. A Review of the Methodological Approaches with Examples of Studies of Selected Aspects of Blood Platelet FunctionDawid Polak, Marcin Talar, Cezary Watala, et al.
European Journal of Pharmacology|June 4, 2010
1-methylnicotinamide effects on the selected markers of endothelial function, inflammation and haemostasis in diabetic ratsTomasz Przygodzki, Piotr Kazmierczak, Joanna Sikora, et al.
Journal of Physiology and Biochemistry|May 6, 2015
Inhibition of cyclooxygenase-2 causes a decrease in coronary flow in diabetic mice. The possible role of PGE2 and dysfunctional vasodilation mediated by prostacyclin receptorTomasz Przygodzki, Marcin Talar, Patrycja Przygodzka, et al.
Scientific Reports|July 1, 2025
A non-binding surface demonstrates increased thrombogenicity under plasma-free conditionsCezary Watala, Boguslawa Luzak, Tomasz Przygodzki, et al.
Journal of Physiology and Biochemistry|January 17, 2012
N-Methyl-2-pyridone-5-carboxamide is 1-methylnicotinamide metabolite of low cyclooxygenase-dependent vasodilating activityTomasz Przygodzki, Bartlomiej Grobelski, Piotr Kazmierczak, et al.
International Journal of Pharmaceutics|January 28, 2014
Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? In the search for minimizing of the adverse effects of PAMAM administrationMagdalena Labieniec-Watala, Tomasz Przygodzki, Katarina Sebekova, et al.
Pageof 4